Reiniš M - Search Results

1

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy.

Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, Moserová I, Fučíková J, Bartůňková J, Špíšek R, Reiniš M. Mikyšková R, et al. Among authors: reinis m. Int J Oncol. 2016 Mar;48(3):953-64. doi: 10.3892/ijo.2015.3314. Epub 2015 Dec 29. Int J Oncol. 2016. PMID: 26718011 Free PMC article.

2

Irradiation of genetically modified plasmacytoma vaccines results in upregulation of CD80 molecule expression, IL-2 production and higher therapeutic efficacy of the vaccines.

Símová J, Reinis M, Sobota V, Capková J, Bubeník J, Jandlová T. Símová J, et al. Among authors: reinis m. Folia Biol (Praha). 2000;46(1):11-5. Folia Biol (Praha). 2000. PMID: 10730877

3

Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors.

Hájková R, Indrová M, Jandlová T, Bubeník J, Reinis M. Hájková R, et al. Among authors: reinis m. Folia Biol (Praha). 1999;45(6):227-31. Folia Biol (Praha). 1999. PMID: 10732718

4

Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth.

Mendoza L, Indrová M, Hájková R, Reinis M, Smahel M, Vonka V, Bubeník J, Jandlová T. Mendoza L, et al. Among authors: reinis m. Folia Biol (Praha). 2000;46(3):91-7. Folia Biol (Praha). 2000. PMID: 10925779

5

Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide.

Indrová M, Bubeník J, Símová J, Vonka V, Nemecková S, Mendoza L, Reinis M. Indrová M, et al. Among authors: reinis m. Int J Mol Med. 2001 Jan;7(1):97-100. doi: 10.3892/ijmm.7.1.97. Int J Mol Med. 2001. PMID: 11115616

6

Bone marrow dendritic cell-based anticancer vaccines.

Indrová M, Mendoza L, Reinis M, Vonka V, Smahel M, Nĕmecková S, Jandlová T, Bubeník J. Indrová M, et al. Among authors: reinis m. Adv Exp Med Biol. 2001;495:355-8. doi: 10.1007/978-1-4615-0685-0_50. Adv Exp Med Biol. 2001. PMID: 11774592 No abstract available.

7

HPV16-associated tumours: therapy of surgical minimal residual disease with dendritic cell-based vaccines.

Reinis M, Indrová M, Mendoza L, Mikysková R, Bieblová J, Bubeník J, Símová J. Reinis M, et al. Int J Oncol. 2004 Oct;25(4):1165-70. Int J Oncol. 2004. PMID: 15375569

8

Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects.

Indrová M, Reinis M, Bubeník J, Jandlová T, Bieblová J, Vonka V, Velek J. Indrová M, et al. Among authors: reinis m. Folia Biol (Praha). 2004;50(6):184-93. Folia Biol (Praha). 2004. PMID: 15709713 Free article.

9

Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I-deficient and -proficient HPV16-associated tumours.

Reinis M, Símová J, Bubeník J. Reinis M, et al. Int J Cancer. 2006 Apr 1;118(7):1836-42. doi: 10.1002/ijc.21546. Int J Cancer. 2006. PMID: 16217768

10

Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.

Indrová M, Bieblová J, Jandlová T, Vonka V, Pajtasz-Piasecka E, Reinis M. Indrová M, et al. Among authors: reinis m. Int J Oncol. 2006 Jan;28(1):253-9. Int J Oncol. 2006. PMID: 16328003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters